Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

Pathogenic potentials of the gastric pathogen, Helicobacter pylori, have been proposed,
evaluated, and confirmed by many laboratories for nearly 4 decades since its serendipitous …

Helicobacter pylori (H. pylori) is transmitted primarily through the oral–oral route and fecal–
oral route. The oral cavity had therefore been hypothesized as an extragastric reservoir of H …

Biofilms and intracellular survival tremendously help Helicobacter pylori (H. pylori) escape
from antibacterial agents attacking, therefore issuing extreme challenges to clinical …

Studies on biofilm-related infections are gaining prominence owing to their involvement in
most clinical infections and seriously threatening global public health. A biofilm is a natural …

Abstract Background Shanghai, in east China, has one of the world's highest burdens of
Helicobacter pylori infection. While multidrug regimens can effectively eradicate H. pylori …

Helicobacter pylori (H. pylori) remains the most-researched etiological factor for gastric
inflammation and malignancies. Its evolution towards gastric complications is dependent …

Helicobacter pylori, a gastric pathogen associated with a broad range of stomach diseases,
has a high tendency to become resistant to antibiotics. One of the most important factors …

Aim: Development of dual-acting antibacterial agents containing Erlotinib, a recognized
EGFR inhibitor used as an anticancer agent, with differently spaced benzenesulfonamide …

The World Health Organization has indicated Helicobacter pylori as a high-priority pathogen
whose infections urgently require an update of the antibacterial treatments pipeline …